Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Korea M&A Highlight: Cosmecca Korea Acquires Englewood Lab

Englewood Lab IPO Preview (Part 2) - Valuation Analysis

Englewood Lab IPO Preview (Part 1) - CEO Presentation to Investors

Update on Cosmecca Korea - Carving Out a Strong Niche in ODM Cosmetics

Cosmecca Korea IPO Preview (Part 2) - What Is It Worth?

Douglas Research Advisory

Event-Driven

<ul>
<li>On 6 February, Cosmecca Korea (241710 KS) launched a partial tender offer on Englewood Lab (950140 KS).</li>
<li>Cosmecca Korea announced that it plans to purchase 11% (2.185 million) of Englewood Lab's outstanding shares at the tender offer price of 10,000 won. </li>
<li>It appears that this partial tender offer is an attempt by Cosmecca Korea to increase its stake in Englewood Lab even further, capitalizing on the lower share price.</li>
</ul>


On 6 February, Cosmecca Korea (241710 KS) launched a partial tender offer on Englewood Lab (950140 KS).
Cosmecca Korea announced that it plans to purchase 11% (2.185 million) of Englewood Lab's outstanding shares at the tender offer price of 10,000 won. 
It appears that this partial tender offer is an attempt by Cosmecca Korea to increase its stake in Englewood Lab even further, capitalizing on the lower share price.


A Partial Tender Offer of Englewood Lab by Cosmecca Korea